市場調查報告書

抗體檢驗的全球市場:慢性疾病的盛行率上升促進需求

Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand

出版商 Persistence Market Research 商品編碼 968211
出版日期 內容資訊 英文 235 Pages
商品交期: 2-3個工作天內
價格
抗體檢驗的全球市場:慢性疾病的盛行率上升促進需求 Global Market Study on Antibody Testing: Rise in Prevalence of Chronic Diseases to Heighten Demand
出版日期: 2020年09月29日內容資訊: 英文 235 Pages
簡介

本報告提供全球抗體檢驗市場相關調查分析,市場動態,市場結構,市場分析與預測,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場涵蓋範圍/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 需求面趨勢
  • 供給方面趨勢

第4章 市場背景

  • 宏觀經濟要素
  • 預測要素:相關性及影響
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會分析
  • COVID-19分析

第5章 主要成功因素

  • 疾病的流行病學
  • 法規形勢
  • 開發平台評估
  • 主要策略:各製造廠商

第6章 全球抗體檢驗市場分析與預測

  • 過去的市場分析
  • 現在、未來市場預測
    • 與前一年同期比較成長率趨勢分析

第7章 全球抗體檢驗市場分析與預測:各產品

  • 簡介/主要調查結果
  • 過去的市場分析:各產品
  • 現在、未來市場分析與預測:各產品
    • 套件
    • 化學藥品、試劑
    • 消耗品
  • 市場魅力分析:各產品類型

第8章 全球抗體檢驗市場分析與預測:各適應症

  • 簡介/主要調查結果
  • 過去的市場分析:各適應症
  • 現在、未來市場分析與預測:各適應症
    • 妊娠
    • 心血管疾病
    • 自體免疫疾病
    • 感染疾病
    • 腫瘤
    • 內分泌疾病
    • 糖尿病
    • 其他
  • 市場魅力分析:各適應症

第9章 全球抗體檢驗市場分析與預測:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場分析:各終端用戶
  • 現在、未來市場分析與預測:各終端用戶
    • 醫院
    • 學術、研究機關
    • 臨床檢驗室
    • 生物製藥企業
    • 居家醫療
  • 市場魅力分析:各終端用戶

第10章 全球抗體檢驗市場分析與預測:各地區

  • 簡介/主要調查結果
  • 過去的市場分析:各地區
  • 現在、未來市場分析與預測:各地區
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東、非洲
  • 市場魅力分析:各地區

第11章 北美的抗體檢驗市場分析與預測

第12章 南美的抗體檢驗市場分析與預測

第13章 歐洲的抗體檢驗市場分析與預測

第14章 東亞的抗體檢驗市場分析與預測

第15章 南亞的抗體檢驗市場分析與預測

第16章 大洋洲的抗體檢驗市場分析與預測

第17章 中東、非洲的抗體檢驗市場分析與預測

第18章 主要國家、新興國家的抗體檢驗市場分析與預測

第19章 市場結構分析

第20章 競爭分析

  • 競爭儀表板
  • 競爭分析
    • Thermo Fisher Scientific.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Beckton, Dickinson and Company
    • F. Hoffmann-La Roche
    • Agilent Technologies
    • DiaSorin
    • Zeus Scientific
    • Abcam
    • Trinity Biotech
    • Werfen (Biokit)
    • Promega
    • BioLegend
    • Meridian Bioscience
    • Bio-Techne (R&D Systems)

第21章 前提條件與簡稱

第22章 調查手法

目錄
Product Code: PMRREP31930

Antibody Testing Market - Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global antibody testing market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global antibody testing market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities of the antibody testing market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the antibody testing market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR's research. This research study can support readers to know the demand for antibody testing and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the antibody testing market, including antibody testing market investors and service providers, and can help them in developing suitable business strategies to flourish in the antibody testing market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the antibody testing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibody testing market are also included in the current study. Depending on potential developments in the antibody testing market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibody testing industry can be aided in making suitable company choices to achieve traction in the antibody testing market.

Key Questions Answered in PMR's Antibody Testing Market Report

Which regions will continue to remain the most profitable regional markets for antibody testing market players?

Which factors will induce a change in the demand for antibody testing during the assessment period?

How will COVID-19 change the trends in the antibody testing market?

How can market players capture the low-hanging opportunities in the antibody testing market in developed regions?

What are the winning strategies of stakeholders in the antibody testing market to upscale their position in this landscape?

What are the restraints that investors need to be aware of and tackle while investing in antibody testing market?

What are the developmental trends in antibody testing sectors that will impact the market?

How can businesses in the antibody testing market avail the growth opportunities in developed and emerging economies?

Antibody Testing Market: Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the antibody testing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the antibody testing market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals, and research scholars using antibody-based test kits, and key executives of product manufacturing companies, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the antibody testing market, and makes PMR's projections on the growth prospects of the antibody testing market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Market Evolution
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Demand Side Trends
  • 3.2. Supply Side Trends

4. Market Background

  • 4.1. Macro-Economic Factors
    • 4.1.1. Global Healthcare Outlook
    • 4.1.2. Global Biotech and Biopharma Industry Outlook
  • 4.2. Forecast Factors - Relevance & Impact
    • 4.2.1. Prevalence of Various Diseases
    • 4.2.2. Historic Growth of Key Manufacturers
    • 4.2.3. Adoption of Antibody Testing Kits
    • 4.2.4. Product in Pipeline
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity Analysis
  • 4.4. COVID-19 Analysis

5. Key Success Factors

  • 5.1. Diseases Epidemiology
  • 5.2. Regulatory Landscape
  • 5.3. Pipeline Assessment
  • 5.4. Key Strategies by Manufacturer

6. Global Antibody Testing Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Product

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2019
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030
    • 7.3.1. Kits
      • 7.3.1.1. Serological Test Kits
        • 7.3.1.1.1. Serological Assay Test Kits
        • 7.3.1.1.2. Serological Rapid Assay Kits
      • 7.3.1.2. Immunoglobulin Kits
        • 7.3.1.2.1. Immunoglobulin Assay Test Kits
        • 7.3.1.2.2. Immunoglobulin Rapid Assay Kits
      • 7.3.1.3. Lateral Flow Assay Kits
        • 7.3.1.3.1. Lateral Flow Assay Test Kits
        • 7.3.1.3.2. Lateral Flow Rapid Assay Kits
    • 7.3.2. Chemical and Reagents
    • 7.3.3. Consumables
  • 7.4. Market Attractiveness Analysis By Product Type

8. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2019
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
    • 8.3.1. Pregnancy
    • 8.3.2. Cardiovascular Diseases
    • 8.3.3. Autoimmune Diseases
    • 8.3.4. Infectious Diseases
    • 8.3.5. Oncology
    • 8.3.6. Endocrine Diseases
    • 8.3.7. Diabetes
    • 8.3.8. Others
  • 8.4. Market Attractiveness Analysis By Indication

9. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
    • 9.3.1. Hospitals
    • 9.3.2. Academic and Research Institutes
    • 9.3.3. Diagnostic Laboratories
    • 9.3.4. Biopharmaceutical Companies
    • 9.3.5. Homecare Settings
  • 9.4. Market Attractiveness Analysis By End User

10. Global Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By Indication
    • 11.3.4. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Key Market Participants - Intensity Mapping
  • 11.6. Drivers and Restraints - Impact Analysis

12. Latin America Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Europe Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis

14. East Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
      • 14.3.1.4.
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis

15. South Asia Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Oceania Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. Key and Emerging Countries Antibody Testing Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. U.S. Antibody Testing Market Analysis
    • 18.2.1. By Product
    • 18.2.2. By Indication
    • 18.2.3. By End User
  • 18.3. Canada Antibody Testing Market Analysis
    • 18.3.1. By Product
    • 18.3.2. By Indication
    • 18.3.3. By End User
  • 18.4. Mexico Antibody Testing Market Analysis
    • 18.4.1. By Product
    • 18.4.2. By Indication
    • 18.4.3. By End User
  • 18.5. Argentina Antibody Testing Market Analysis
    • 18.5.1. By Product
    • 18.5.2. By Indication
    • 18.5.3. By End User
  • 18.6. Brazil Antibody Testing Market Analysis
    • 18.6.1. By Product
    • 18.6.2. By Indication
    • 18.6.3. By End User
  • 18.7. U.K. Antibody Testing Market Analysis
    • 18.7.1. By Product
    • 18.7.2. By Indication
    • 18.7.3. By End User
  • 18.8. Germany Antibody Testing Market Analysis
    • 18.8.1. By Product
    • 18.8.2. By Indication
    • 18.8.3. By End User
  • 18.9. France Antibody Testing Market Analysis
    • 18.9.1. By Product
    • 18.9.2. By Indication
    • 18.9.3. By End User
  • 18.10. Italy Antibody Testing Market Analysis
    • 18.10.1. By Product
    • 18.10.2. By Indication
    • 18.10.3. By End User
  • 18.11. Spain Antibody Testing Market Analysis
    • 18.11.1. By Product
    • 18.11.2. By Indication
    • 18.11.3. By End User
  • 18.12. Russia Antibody Testing Market Analysis
    • 18.12.1. By Product
    • 18.12.2. By Indication
    • 18.12.3. By End User
  • 18.13. China Antibody Testing Market Analysis
    • 18.13.1. By Product
    • 18.13.2. By Indication
    • 18.13.3. By End User
  • 18.14. Japan Antibody Testing Market Analysis
    • 18.14.1. By Product
    • 18.14.2. By Indication
    • 18.14.3. By End User
  • 18.15. South Korea Antibody Testing Market Analysis
    • 18.15.1. By Product
    • 18.15.2. By Indication
    • 18.15.3. By End User
  • 18.16. India Antibody Testing Market Analysis
    • 18.16.1. By Product
    • 18.16.2. By Indication
    • 18.16.3. By End User
  • 18.17. Indonesia Antibody Testing Market Analysis
    • 18.17.1. By Product
    • 18.17.2. By Indication
    • 18.17.3. By End User
  • 18.18. Malaysia Antibody Testing Market Analysis
    • 18.18.1. By Product
    • 18.18.2. By Indication
    • 18.18.3. By End User
  • 18.19. Australia Antibody Testing Market Analysis
    • 18.19.1. By Product
    • 18.19.2. By Indication
    • 18.19.3. By End User
  • 18.20. New Zealand Antibody Testing Market Analysis
    • 18.20.1. By Product
    • 18.20.2. By Indication
    • 18.20.3. By End User
  • 18.21. GCC Countries Antibody Testing Market Analysis
    • 18.21.1. By Product
    • 18.21.2. By Indication
    • 18.21.3. By End User
  • 18.22. Turkey Antibody Testing Market Analysis
    • 18.22.1. By Product
    • 18.22.2. By Indication
    • 18.22.3. By End User
  • 18.23. South Africa Antibody Testing Market Analysis
    • 18.23.1. By Product
    • 18.23.2. By Indication
    • 18.23.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Thermo Fisher Scientific.
      • 20.2.1.1. Company Overview
      • 20.2.1.2. Product Overview
      • 20.2.1.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. Strategy Overview
        • 20.2.1.5.1. Marketing Strategy
        • 20.2.1.5.2. Service Strategy
        • 20.2.1.5.3. Channel Strategy
    • 20.2.2. Abbott Laboratories
      • 20.2.2.1. Company Overview
      • 20.2.2.2. Product Overview
      • 20.2.2.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. Strategy Overview
        • 20.2.2.5.1. Marketing Strategy
        • 20.2.2.5.2. Service Strategy
        • 20.2.2.5.3. Channel Strategy
    • 20.2.3. Bio-Rad Laboratories, Inc.
      • 20.2.3.1. Company Overview
      • 20.2.3.2. Product Overview
      • 20.2.3.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. Strategy Overview
        • 20.2.3.5.1. Marketing Strategy
        • 20.2.3.5.2. Service Strategy
        • 20.2.3.5.3. Channel Strategy
    • 20.2.4. Beckton, Dickinson and Company
      • 20.2.4.1. Company Overview
      • 20.2.4.2. Product Overview
      • 20.2.4.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. Strategy Overview
        • 20.2.4.5.1. Marketing Strategy
        • 20.2.4.5.2. Service Strategy
        • 20.2.4.5.3. Channel Strategy
    • 20.2.5. F. Hoffmann-La Roche
      • 20.2.5.1. Company Overview
      • 20.2.5.2. Product Overview
      • 20.2.5.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. Strategy Overview
        • 20.2.5.5.1. Marketing Strategy
        • 20.2.5.5.2. Service Strategy
        • 20.2.5.5.3. Channel Strategy
    • 20.2.6. Agilent Technologies
      • 20.2.6.1. Company Overview
      • 20.2.6.2. Product Overview
      • 20.2.6.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. Strategy Overview
        • 20.2.6.5.1. Marketing Strategy
        • 20.2.6.5.2. Service Strategy
        • 20.2.6.5.3. Channel Strategy
    • 20.2.7. DiaSorin
      • 20.2.7.1. Company Overview
      • 20.2.7.2. Product Overview
      • 20.2.7.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. Strategy Overview
        • 20.2.7.5.1. Marketing Strategy
        • 20.2.7.5.2. Service Strategy
        • 20.2.7.5.3. Channel Strategy
    • 20.2.8. Zeus Scientific
      • 20.2.8.1. Company Overview
      • 20.2.8.2. Product Overview
      • 20.2.8.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.8.4. Sales Footprint
      • 20.2.8.5. Strategy Overview
        • 20.2.8.5.1. Marketing Strategy
        • 20.2.8.5.2. Service Strategy
        • 20.2.8.5.3. Channel Strategy
    • 20.2.9. Abcam
      • 20.2.9.1. Company Overview
      • 20.2.9.2. Product Overview
      • 20.2.9.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.9.4. Sales Footprint
      • 20.2.9.5. Strategy Overview
        • 20.2.9.5.1. Marketing Strategy
        • 20.2.9.5.2. Service Strategy
        • 20.2.9.5.3. Channel Strategy
    • 20.2.10. Trinity Biotech
      • 20.2.10.1. Company Overview
      • 20.2.10.2. Product Overview
      • 20.2.10.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.10.4. Sales Footprint
      • 20.2.10.5. Strategy Overview
        • 20.2.10.5.1. Marketing Strategy
        • 20.2.10.5.2. Service Strategy
        • 20.2.10.5.3. Channel Strategy
    • 20.2.11. Werfen (Biokit)
      • 20.2.11.1. Company Overview
      • 20.2.11.2. Product Overview
      • 20.2.11.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.11.4. Sales Footprint
      • 20.2.11.5. Strategy Overview
        • 20.2.11.5.1. Marketing Strategy
        • 20.2.11.5.2. Service Strategy
        • 20.2.11.5.3. Channel Strategy
    • 20.2.12. Promega
      • 20.2.12.1. Company Overview
      • 20.2.12.2. Product Overview
      • 20.2.12.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.12.4. Sales Footprint
      • 20.2.12.5. Strategy Overview
        • 20.2.12.5.1. Marketing Strategy
        • 20.2.12.5.2. Service Strategy
        • 20.2.12.5.3. Channel Strategy
    • 20.2.13. BioLegend
      • 20.2.13.1. Company Overview
      • 20.2.13.2. Product Overview
      • 20.2.13.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.13.4. Sales Footprint
      • 20.2.13.5. Strategy Overview
        • 20.2.13.5.1. Marketing Strategy
        • 20.2.13.5.2. Service Strategy
        • 20.2.13.5.3. Channel Strategy
    • 20.2.14. Meridian Bioscience
      • 20.2.14.1. Company Overview
      • 20.2.14.2. Product Overview
      • 20.2.14.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.14.4. Sales Footprint
      • 20.2.14.5. Strategy Overview
        • 20.2.14.5.1. Marketing Strategy
        • 20.2.14.5.2. Service Strategy
        • 20.2.14.5.3. Channel Strategy
    • 20.2.15. Bio-Techne (R&D Systems)
      • 20.2.15.1. Company Overview
      • 20.2.15.2. Product Overview
      • 20.2.15.3. Profitability by Market Segments (Service/Channel/Region)
      • 20.2.15.4. Sales Footprint
      • 20.2.15.5. Strategy Overview
        • 20.2.15.5.1. Marketing Strategy
        • 20.2.15.5.2. Service Strategy
        • 20.2.15.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables:

  • Table 01: COVID-19 Region-wise Analysis
  • Table 02: Pipeline Assessment of Antibody Tests
  • Table 03: Global Antibody Testing Market Value (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 04: Global Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 05: Global Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End User
  • Table 06: Global Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Region
  • Table 07: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 08: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 09: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 10: North America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 11: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 12: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 13: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 14: Latin America Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 15: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 16: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 17: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 18: Europe Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 19: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 20: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 21: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 22: East Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 23: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 24: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 25: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 26: South Asia Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 27: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 28: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 29: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 30: Oceania Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users
  • Table 31: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Country
  • Table 32: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Product Type
  • Table 33: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by Indication
  • Table 34: MEA Antibody Testing Market (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, by End Users

List of Figures:

  • Figure 01: Antibody Testing Market Share by, Product (2020)
  • Figure 02: Antibody Testing Market Share by, Indication (2020)
  • Figure 03: Antibody Testing Market Share by, End User (2020)
  • Figure 04: Antibody Testing Market Share by, Region (2020)
  • Figure 05: Historical Market Value (US$ Mn) Analysis, 2015-2019
  • Figure 06: Y-o-Y Growth Trend Analysis
  • Figure 07: Absolute $ Opportunity Analysis
  • Figure 08: Global Antibody Testing Market Share Analysis (%) by Product Type, 2020& 2030
  • Figure 09: Global Antibody Testing Market Y-o-Y Growth (%) by Product Type, 2020-2030
  • Figure 10: Global Antibody Testing Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 11: Global Antibody Testing Market Share Analysis (%) by Indication, 2020 & 2030
  • Figure 12: Global Antibody Testing Market Y-o-Y Growth (%) by Indication, 2020-2030
  • Figure 13: Global Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 14: Global Antibody Testing Market Share Analysis (%) by End User, 2020 & 2030
  • Figure 15: Global Antibody Testing Market Y-o-Y Growth (%) by End User, 2020-2030
  • Figure 16: Global Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 17: Global Antibody Testing Market Share Analysis (%) by Region, 2020 & 2030
  • Figure 18: Global Antibody Testing Market Y-o-Y Growth (%) by Region, 2020-2030
  • Figure 19: Global Antibody Testing Market Attractiveness Analysis by Region, 2020-2030
  • Figure 20: North America Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 21: North America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 22: North America Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 23: North America Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 24: North America Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 25: North America Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 26: Latin America Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 27: Latin America Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 28: Latin America Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 29: Latin America Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 30: Latin America Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 31: Latin America Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 32: Europe Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 33: Europe Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 34: Europe Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 35: Europe Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 36: Europe Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 37: Europe Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 38: East Asia Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 39: East Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 40: East Asia Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 41: East Asia Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 42: East Asia Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 43: East Asia Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 44: South Asia Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 45: South Asia Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 46: South Asia Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 47: South Asia Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 48: South Asia Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 49: South Asia Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 50: Oceania Antibody Testing Market(US$ Mn) Analysis, 2015-2019
  • Figure 51: Oceania Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 52: Oceania Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 53: Oceania Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 54: Oceania Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 55: Oceania Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 56: MEA Antibody Testing Market (US$ Mn) Analysis, 2015-2019
  • Figure 57: MEA Antibody Testing Market (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 58: MEA Antibody Testing Market Attractiveness Analysis by Product, 2020-2030
  • Figure 59: MEA Antibody Testing Market Attractiveness Analysis by Indication, 2020-2030
  • Figure 60: MEA Antibody Testing Market Attractiveness Analysis by End User, 2020-2030
  • Figure 61: MEA Antibody Testing Market Attractiveness Analysis by Country, 2020-2030
  • Figure 62: U.S. Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 63: U.S. Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 64: U.S. Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 65: Canada Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 66: Canada Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 67: Canada Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 68: Brazil Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 69: Brazil Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 70: Brazil Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 71: Mexico Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 72: Mexico Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 73: Mexico Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 74: Argentina Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 75: Argentina Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 76: Argentina Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 77: Rest of Latin America Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 78: Rest of Latin America Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 79: Rest of Latin America Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 80: U.K. Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 81: U.K. Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 82: U.K. Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 83: Germany Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 84: Germany Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 85: Germany Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 86: France Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 87: France Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 88: France Antibody Testing Market Share Analysis %), by End User, 2019
  • Figure 89: Italy Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 90: Italy Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 91: Italy Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 92: Spain Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 93: Spain Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 94: Spain Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 95: Russia Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 96: Russia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 97: Russia Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 98: Rest of Europe Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 99: Rest of Europe Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 100: Rest of Europe Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 101: China Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 102: China Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 103: China Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 104: Japan Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 105: Japan Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 106: Japan Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 107: South Korea Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 108: South Korea Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 109: South Korea Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 110: India Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 111: India Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 112: India Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 113: Malaysia Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 114: Malaysia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 115: Malaysia Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 116: Indonesia Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 117: Indonesia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 118: Indonesia Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 119: Rest of South Asia Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 120: Rest of South Asia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 121: Rest of South Asia Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 122: Australia Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 123: Australia Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 124: Australia Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 125: New Zealand Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 126: New Zealand Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 127: New Zealand Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 128: GCC Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 129: GCC Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 130: GCC Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 131: Turkey Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 132: Turkey Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 133: Turkey Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 134: South Africa Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 135: South Africa Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 136: South Africa Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 137: North Africa Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 138: North Africa Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 139: North Africa Antibody Testing Market Share Analysis (%), by End User, 2019
  • Figure 140: Rest of MEA Antibody Testing Market Share Analysis (%), by Product, 2019
  • Figure 141: Rest of MEA Antibody Testing Market Share Analysis (%), By, Indication, 2019 & 2030
  • Figure 142: Rest of MEA Antibody Testing Market Share Analysis (%), by End User, 2019